Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2005
10/05/2005EP1581259A1 Method and material for specific proliferation promotion of lymphocyte sub-populations by means of a combination of an immunomodulator with a non-water-soluble natural product and a carrier
10/05/2005EP1581229A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
10/05/2005EP1581225A1 Combination therapy for the treatment of pain
10/05/2005EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
10/05/2005EP1581206A1 Treatment of inflammatory disorders with 2,3-benzodiazepines
10/05/2005EP1581165A2 Novel factor viia inhibiting compounds
10/05/2005EP1516866A9 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/05/2005EP1370271B1 A process for the manufacture of a herbal composition comprising a matrine
10/05/2005EP1368007B1 Coating and binding agent for pharmaceutical formulations with improved storage stability
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1678744A Human antihuman interleukin-6 antibody and fragment of the antibody
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678620A Macrolide compounds endowed with antiinflammatory activity
10/05/2005CN1678619A Compounds that interact with kinases
10/05/2005CN1678611A Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678350A Remedy
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678329A Probiotics for gut neuromuscular functions
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678308A Indometacin preparation for external use
10/05/2005CN1678306A -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
10/05/2005CN1678297A Method of treating osteoarthritis
10/05/2005CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676508A Anti-inflammatory and anti-thrombus compound and its medicinal composition
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1676159A Total flavone of citrus grandis osbeckvar tomentosa hort peridium, and its extracting method and use
10/05/2005CN1676156A Chinese medicine composition for treating rheumatic rheumatoid arthritis
10/05/2005CN1676155A Chinese medicine composition for treating rheumatism
10/05/2005CN1676154A Chinese medicine composition for treating rheumatic rheumatoid arthritis
10/05/2005CN1676153A Chinese medicine composition for treating rheumatic rheumatoid arthritis
10/05/2005CN1676143A Chinese medicine compound formulation for treating rheumatism
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221257C Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treatment of neurogenic inflammation
10/05/2005CN1221237C Composition for treatment of scars skin disease
10/04/2005US6951942 Glucocorticoid-selective anti-inflammatory agents
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951937 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951885 Pharmaceutical composition
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005US6951861 Chemical compounds
10/04/2005US6951859 Anticancer agents; diseases associated with signal trans-duction pathways operating through growth factor receptors
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951841 Bioavailability; side effect reduction
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951657 Particles coated with granulated crystalline ibuprofen
10/04/2005CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g
09/2005
09/30/2005CA2499791A1 Angptl4/fiaf as marker for ppardelta modulation
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089800A1 PHARMACEUTICAL COMPOSITION CONTAINING hsHRD3
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2004072037A8 2,3'-bipyridines derivatives as selective cox-2 inhibitors
09/29/2005US20050215786 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,,2,4-triazol-3-one
09/29/2005US20050215633 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means
09/29/2005US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215565 Using sulfonamides such as N-[N-(3-pyridinesulfonyl)-L-3,3-dimethyl-4-thiaprolyl]-O-[1-methylpiperazin-4-ylcarbonyl]-L-tyrosine isopropyl ester optionally with immunoglobulins, steroids, antiinflammatory agents
09/29/2005US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia
09/29/2005US20050215520 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid
09/29/2005US20050215480 Alpha conotoxin peptides with analgesic properties
09/29/2005US20050215470 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis
09/29/2005US20050214903 O-superfamily conotoxin peptides
09/29/2005US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins
09/29/2005US20050214761 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids
1 ... 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 ... 1272